Fingerprint
Dive into the research topics of 'Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically